This article is more than 5 years old. Information may no longer be current.

Five most viewed news stories of May

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Healio Rheumatology has put together a compilation of the five most viewed news stories from May to keep you up-to-date on the current hot topics in rheumatology.

Study explores link between rheumatoid arthritis, cardiovascular disease

DESTIN, Fla. – A speaker at the Congress of Clinical Rheumatology presented data that address the effect of rheumatoid arthritis therapies on cardiovascular and metabolic disease. Read more.

Rituximab decreased disease activity in patients with severe or refractory SLE

Treatment of systemic lupus erythematosus (SLE) with rituximab effectively decreased disease activity, with a low incidence of adverse effects, in patients with severe or refractory disease, according to results of a long-term study at a single center. Read more.

Similar results seen in PsA patients treated with etanercept alone or in combination with methotrexate

Similar proportions of patients with psoriatic arthritis (PsA) who received monotherapy with etanercept compared to patients who received both etanercept and methotrexate met the psoriatic arthritis response criteria and few between-group differences were seen, according to recently published data.  Read more.

Small risk of hepatitis B virus reactivation seen after treatment with rituximab for RA

Patients with rheumatoid arthritis (RA) with resolved hepatitis B virus experienced a low risk of hepatitis B virus reactivation after the administration of rituximab combined with disease-modifying antirheumatic drugs, according to results. Read more.

Global survey reveals dissonance in physician-patient communication for RA management

Global surveys assessing the relationship between physician-patient communication and overall rheumatoid arthritis (RA) disease management revealed disconnects between patients and physicians across multiple aspects of management, according to a report released by Pfizer. Read more.